These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1466 related items for PubMed ID: 17854425

  • 1. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J.
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [Abstract] [Full Text] [Related]

  • 2. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M.
    Cancer; 1997 Dec 01; 80(11):2060-7. PubMed ID: 9392327
    [Abstract] [Full Text] [Related]

  • 3. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep 01; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y, Tani M, Kurata T, Abe K.
    Cancer; 1996 May 01; 77(9):1787-91. PubMed ID: 8646675
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
    Suga M, Senota A, Arima K, Kodama T, Ikuta S, Sakamoto H, Ohe Y, Sugai S, Yachi A.
    Hepatogastroenterology; 1994 Oct 01; 41(5):438-41. PubMed ID: 7531667
    [Abstract] [Full Text] [Related]

  • 6. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E, European Concerted Action on Viral Hepatitis (EUROHEP).
    Am J Gastroenterol; 2002 Nov 01; 97(11):2886-95. PubMed ID: 12425564
    [Abstract] [Full Text] [Related]

  • 7. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M.
    Alcohol Clin Exp Res; 2003 Aug 01; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [Abstract] [Full Text] [Related]

  • 8. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May 01; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 9. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
    Shim J, Kim BH, Kim NH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R.
    J Gastroenterol Hepatol; 2005 May 01; 20(5):746-51. PubMed ID: 15853989
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan real-time PCR.
    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A.
    Intervirology; 2007 May 01; 50(4):241-4. PubMed ID: 17446712
    [Abstract] [Full Text] [Related]

  • 11. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.
    Korean J Hepatol; 2008 Mar 01; 14(1):67-76. PubMed ID: 18367859
    [Abstract] [Full Text] [Related]

  • 12. A comparison of hepatocellular carcinoma associated with HBV or HCV infection.
    Tanabe G, Nuruki K, Baba Y, Imamura Y, Miyazono N, Ueno K, Arima T, Nakajyou M, Aikou T.
    Hepatogastroenterology; 1999 Mar 01; 46(28):2442-6. PubMed ID: 10522016
    [Abstract] [Full Text] [Related]

  • 13. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma.
    Chen MF, Jeng LB, Lee WC, Chen TC.
    Surgery; 1998 May 01; 123(5):554-9. PubMed ID: 9591008
    [Abstract] [Full Text] [Related]

  • 14. [Analysis of hepatitis virus infection in hepatocellular carcinoma patients receiving surgical operation in China and Japan].
    Yuan P, Tang W, Wen J, Li QM, Luo H, Liang BH, Zheng QM, Wei L.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Sep 01; 39(5):332-4. PubMed ID: 16266545
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T, Müller HM, Solbach C, Toex U, Kommerell B, Theilmann L.
    Cancer Epidemiol Biomarkers Prev; 1994 Jun 01; 3(4):311-5. PubMed ID: 8061579
    [Abstract] [Full Text] [Related]

  • 16. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Jun 01; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 17. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    J Clin Gastroenterol; 2009 Jun 01; 43(5):482-8. PubMed ID: 19197197
    [Abstract] [Full Text] [Related]

  • 18. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.
    J Med Virol; 2003 Dec 01; 71(4):492-8. PubMed ID: 14556260
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
    Resnick RH, Koff R.
    Arch Intern Med; 1993 Jul 26; 153(14):1672-7. PubMed ID: 7687423
    [Abstract] [Full Text] [Related]

  • 20. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody.
    Tanaka K, Shimada H, Matsuo K, Nagano Y, Endo I, Togo S.
    Ann Surg Oncol; 2007 Mar 26; 14(3):1170-81. PubMed ID: 17195904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.